APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 302 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,020,697 | -34.3% | 78,746 | +0.6% | 0.09% | -34.6% |
| Q1 2024 | $4,599,711 | -1.8% | 78,253 | +0.0% | 0.13% | -10.7% |
| Q4 2023 | $4,683,806 | +57.1% | 78,246 | -0.2% | 0.15% | +41.9% |
| Q3 2023 | $2,981,575 | -58.4% | 78,380 | -0.4% | 0.10% | -53.1% |
| Q2 2023 | $7,168,386 | -40.2% | 78,687 | -56.7% | 0.22% | -44.0% |
| Q1 2023 | $11,996,607 | +27.2% | 181,877 | -0.3% | 0.40% | +18.7% |
| Q4 2022 | $9,433,869 | – | 182,438 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |